INCY
NASDAQ
US
Incyte Corporation - Common Stock
$95,93
▲ +$1,63
(+1,73%)
Vol 1.2M
13
Skor Kualitas
ok
Pemeriksaan Mendalam
2/5
ok
Pendapatan ✓
Laba Bersih ✓
>IPO ✗
Kap. Pasar
$19.4B
P/E
16,3
ROE
29,8%
Margin
24,7%
D/E
0,76
Beta
0,82
52W
$54–$109
Konsensus Wall Street
33 analis · Apr 20268
Beli Kuat
8
Beli
16
Tahan
1
Jual
0
Jual Kuat
48,5%
Peringkat Beli
Grafik Harga
Saham Serupa
BIIB
Biogen Inc
P/E 16,0
$25.8B
UTHR
United Therapeutics Corp
P/E 16,5
$21.0B
RVMD
Revolution Medicines Inc
$15.4B
MRNA
Moderna Inc
$11.5B
SMMT
Summit Therapeutics Inc
$13.0B
BBIO
BridgeBio Pharma Inc
$14.7B
NBIX
Neurocrine Biosciences Inc
P/E 33,0
$14.1B
MDGL
Madrigal Pharmaceuticals Inc
$13.2B
IONS
Ionis Pharmaceuticals Inc
$12.8B
EXEL
Exelixis Inc
P/E 17,3
$11.8B
Pendapatan
Tingkat beat: 75,0%| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Des 2025 | $1,97 | $1,80 | $-0,17 |
| Sep 2025 | $1,69 | $2,26 | +$0,57 |
| Jun 2025 | $1,50 | $1,57 | +$0,07 |
| Mar 2025 | $1,04 | $1,16 | +$0,12 |
Tren Fundamental
| Metrik | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 24.1% | 24.1% | 24.1% | 24.1% | 29.8% | 29.8% |
| P/E (TTM) | 15.14 | 19.33 | 19.44 | 21.07 | 16.76 | 16.31 |
| Net Margin | 33.3% | 19.0% | 19.0% | 19.0% | 24.7% | 24.7% |
| Gross Margin | 94.0% | 93.4% | 93.4% | 93.4% | 93.5% | 93.5% |
| D/E Ratio | 0.87 | 0.87 | 0.87 | 0.87 | 0.76 | 0.76 |
| Current Ratio | 2.85 | 2.85 | 2.85 | 2.85 | 3.20 | 3.20 |
Rasio Utama
ROA (TTM)
20,4%
P/S (TTM)
4,03
P/B
3,9
EPS (TTM)
$5,91
CF/Share
$2,23
Pertumbuhan Pendapatan 3T
+12,4%
52W High
$109,28
52W Low
$53,56
$53,56
Rentang 52 Minggu
$109,28
Як INCY виглядає на тлі конкурентів у Biotechnology?
Група порівняння: Micro-cap Biotechnology (All) · 528 компаній
Оцінка INCY vs аналоги Biotechnology
P/E
16,3
▼
13%
di bawah
rekan
(18,8)
vs Rekan
vs Industri
Undervalued
P/S
4,0
▼
69%
di bawah
rekan
(12,9)
vs Rekan
vs Industri
Undervalued
P/B
3,9
▲
57%
di atas
rekan
(2,5)
vs Rekan
vs Industri
Overvalued
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(0,0%)
vs Rekan
vs Industri
Yield rendah
Прибутковість INCY vs аналоги Biotechnology
ROE
29,8%
▲
144%
di atas
rekan
(-67,3%)
vs Rekan
vs Industri
Tingkat atas
Net margin
24,7%
▲
109%
di atas
rekan
(-286,8%)
vs Rekan
vs Industri
Di bawah rata-rata
Валова маржа
93,5%
▲
19%
di atas
rekan
(78,6%)
vs Rekan
vs Industri
Lemah
ROA
20,4%
▲
144%
di atas
rekan
(-46,7%)
vs Rekan
vs Industri
Tingkat atas
Фінансове здоровʼя INCY vs аналоги Biotechnology
D/E ratio
0,8
▼
0%
di bawah
rekan
(0,0)
vs Rekan
vs Industri
Sejajar
Поточна ліквідність
3,2
▼
28%
di bawah
rekan
(4,4)
vs Rekan
vs Industri
Likuiditas rendah
Beta
0,8
▼
15%
di bawah
rekan
(1,0)
vs Rekan
vs Industri
Kurang volatil
Радар фундаменталів INCY
INCY
Median rekan
Industri
INCY прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
INCY vs аналоги: ключові метрики
Sinyal Terkait
Opini AI Terbaru
Grok
SKIP
Price action shows a clear downtrend over the past several weeks, with closes dropping from 108.92 on 2026-02-09 to 91.77 currently, breaking below key support around 97-100, and low volume on the latest bar suggesting lack of buying interest, making …
Mar 23, 2026Berita Terbaru
Belum ada berita terkait